Astec Lifesciences
ASTEC · Agriculture > Pesticides & Agrochemicals · Chairman: Nadir B Godrej · MD: Ashok V Hiremath · Listing date: Nov. 26, 2009 · Employees: 473 · Mumbai · http://www.astecls.com

Stock Price vs Company Growth
1d
1.3%
1w
4.5%
1m
14.6%
3m
21.5%
6m
8.2%
1y
26.2%
5y
14.7%
10y
5.0%
all
13.2%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 590 1.3%
566
849
Company Overview

Sales
441 Cr
Growth: 7.6%
Profit after Tax
-66.6 Cr
Growth: -17.7%
Small Cap
1,314 Cr
P/S: 3.0x
Industry P/S: 1.3x
Fundamentals

Sales (Cr) ₹ 441
Growth 7.6%
EBITDA 1.3%
P/S 3.0x
Dividend 0.0%
P/E -19.4x
Book Value ₹ 167
PEG Ratio -2.6x
ROE -24.1%
P/B 3.6x
Shareholding Pattern

Institutions
Icici Prudential Multicap Fund
2.56 %
Icici Lombard General Insurance Company Ltd
2.15 %
Nippon Life India Trustee Ltd-A/C Nippon India Value Fund
1.02 %
Promoters
Godrej Agrovet Limited
63.33 %
Ashok Vishwanath Hiremath
1.88 %
Others
Shreans Daga
2.11 %
Kaushik Daga
2.04 %
Own Infracon Private Limited
1.15 %
Iepf
0.04 %
Increase    Decrease    No change
Company Profile Detailed

Astec is proud of its rich experience of over two decades in the chemical industry. The company employs highly qualified and trained personnel to monitor and maintain its manufacturing activities as well as process development work. Astec prides itself in being responsive, reliable and quick to implement projects. A strong R&D focus has enabled the company to introduce a number of unique products.
Investors (82)
Followers (5)